ArticleMethodsX2026
A leakage-aware entropy screening protocol for structured biomarker panel evaluation in ovarian cancer risk modelling.
Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In biomedical risk modeling, entropy-based feature screening is being increasingly used, but covariance statistics have been commonly calculated based on entire datasets before validation. It may introduce a small amount of information leakage and spur a perceived panel synergy especially when administrative or post-outcome variables are present. This article presents a leakage-aware entropy screening protocol for structured biomarker panel evaluation. The workflow integrates (i) systematic administrative variable auditing, (ii) fold-restricted von Neumann entropy estimation derived from covariance-based density matrices, and (iii) cross-validated predictive benchmarking within a unified implementation framework. Entropy computation is strictly confined to training partitions under stratified cross-validation, and panel definitions are fixed prior to analysis to avoid grouping bias. The protocol is demonstrated using a structured ovarian cancer dataset from the PLCO Cancer Screening Trial to illustrate leakage-controlled panel-level entropy estimation and validation-consistent benchmarking. The workflow provides an auditable and reproducible framework for multivariate panel screening and is adaptable to other structured biomedical datasets requiring grouped feature evaluation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.